Home > Financial Ratios > SAKAR HEALTHCARE

SAKAR HEALTHCARE
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for SAKAR HEALTHCARE
Please provide your vote to see the results

SAKAR HEALTHCARE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 9.5620.4132.4710.29-

What is the latest Core EBITDA Growth ratio of SAKAR HEALTHCARE ?

The latest Core EBITDA Growth ratio of SAKAR HEALTHCARE is 9.56 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar20249.56
Mar202320.41
Mar202232.47
Mar202110.29
Mar2020-

How is Core EBITDA Growth of SAKAR HEALTHCARE Trending?

Years Core EBITDA Growth % Change
Mar2024 9.56
-53.16
Mar2023 20.41
-37.14
Mar2022 32.47
215.55
Mar2021 10.29
0
Mar2020 0 -

Other Financial Ratios of SAKAR HEALTHCARE


Compare Core EBITDA Growth ratio of peers of SAKAR HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAKAR HEALTHCARE ₹729.7 Cr -3.6% -5.3% 11.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹380,702.0 Cr -3.3% -4.6% -7.9% Stock Analytics
DIVIS LABORATORIES ₹156,908.0 Cr -9% -13.6% 24% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,896.0 Cr -1.1% 7% 8.2% Stock Analytics
CIPLA ₹119,988.0 Cr -2% 0.6% -4% Stock Analytics
DR REDDYS LABORATORIES ₹101,122.0 Cr -1.1% -3.8% -13.3% Stock Analytics


SAKAR HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAKAR HEALTHCARE

-3.6%

-5.3%

11.1%

SENSEX

-0.9%

-4.4%

1.6%


You may also like the below Video Courses